Zimmer Biomet reported third quarter net sales of $1.929 billion, a 2.0% increase over the prior year, and diluted earnings per share of $1.16. Adjusted diluted earnings per share were $1.81, a 2.3% increase over the prior year.
Third quarter net sales of $1.929 billion increased 2.0%, and increased 1.1% on a constant currency basis
Third quarter net sales of $1.929 billion increased 2.0%, and increased 1.1% on a constant currency basis
Third quarter diluted earnings per share were $1.16; adjusted diluted earnings per share were $1.81
Third quarter diluted earnings per share were $1.16; adjusted diluted earnings per share were $1.81
Zimmer Biomet is not providing fourth quarter financial guidance at this time due to the uncertainty around the scope and duration of COVID-19 and its ongoing impact.
Visualization of income flow from segment revenue to net income